MUCOPOLYSACCHARIDOSIS MPS TYPE VI MAROTEAUX LAMY QUANTITATIVE BLOOD Test
Test Name: MUCOPOLYSACCHARIDOSIS MPS TYPE VI MAROTEAUX LAMY QUANTITATIVE BLOOD Test
Components: Price 380.0 AED
Sample Condition: 10 mL (7.5 mL min.) whole blood from 3 Lavender Top (EDTA) OR Green Top (Sodium Heparin) tubes. Ship refrigerated. DO NOT FREEZE. Provide brief clinical history.
Report Delivery: Sample Daily by 4 pm; Report 4 days
Method: Enzyme assay
Test type: Inborn errors of metabolism
Doctor: Pediatrician
Test Department: GENETIC
Pre Test Information: Provide brief clinical history.
Test Details:
A quantitative blood test for Mucopolysaccharidosis (MPS) Type VI, also known as Maroteaux-Lamy syndrome, measures the levels of the enzyme arylsulfatase B (ASB) in the blood. MPS Type VI is a rare genetic disorder characterized by the deficiency or malfunctioning of this enzyme, leading to the accumulation of certain complex carbohydrates called glycosaminoglycans (GAGs) in various tissues and organs.
To perform the quantitative blood test, a blood sample is taken from the individual and sent to a laboratory for analysis. The laboratory measures the activity or levels of ASB in the blood using specialized techniques. If the levels of ASB are significantly reduced or absent, it indicates a possible diagnosis of MPS Type VI.
This quantitative blood test helps in the diagnosis and monitoring of MPS Type VI. It can be used to confirm a suspected diagnosis based on clinical symptoms and other diagnostic tests. Additionally, it can be used to assess the effectiveness of enzyme replacement therapy (ERT) in individuals receiving treatment for MPS Type VI.
It is important to note that a quantitative blood test for MPS Type VI is just one component of the diagnostic process. Other diagnostic tests, such as urine analysis, genetic testing, and imaging studies, may also be necessary to confirm the diagnosis and evaluate the extent of organ involvement. A consultation with a medical geneticist or a specialist in metabolic disorders is recommended for accurate diagnosis and management of MPS Type VI.
Test Name | MUCOPOLYSACCHARIDOSIS MPS TYPE VI MAROTEAUX LAMY QUANTITATIVE BLOOD Test |
---|---|
Components | |
Price | 380.0 AED |
Sample Condition | 10 mL (7.5 mL min.) whole blood from 3 Lavender Top (EDTA)OR Green Top (Sodium Heparin) tubes. Ship refrigerated. DO NOT FREEZE. Provide brief clinical history. |
Report Delivery | Sample Daily by 4 pm; Report 4 days |
Method | Enzyme assay |
Test type | Inborn errors of metabolism |
Doctor | Pediatrician |
Test Department: | GENETIC |
Pre Test Information | Provide brief clinical history. |
Test Details |
A quantitative blood test for Mucopolysaccharidosis (MPS) Type VI, also known as Maroteaux-Lamy syndrome, measures the levels of the enzyme arylsulfatase B (ASB) in the blood. MPS Type VI is a rare genetic disorder characterized by the deficiency or malfunctioning of this enzyme, leading to the accumulation of certain complex carbohydrates called glycosaminoglycans (GAGs) in various tissues and organs. To perform the quantitative blood test, a blood sample is taken from the individual and sent to a laboratory for analysis. The laboratory measures the activity or levels of ASB in the blood using specialized techniques. If the levels of ASB are significantly reduced or absent, it indicates a possible diagnosis of MPS Type VI. This quantitative blood test helps in the diagnosis and monitoring of MPS Type VI. It can be used to confirm a suspected diagnosis based on clinical symptoms and other diagnostic tests. Additionally, it can be used to assess the effectiveness of enzyme replacement therapy (ERT) in individuals receiving treatment for MPS Type VI. It is important to note that a quantitative blood test for MPS Type VI is just one component of the diagnostic process. Other diagnostic tests, such as urine analysis, genetic testing, and imaging studies, may also be necessary to confirm the diagnosis and evaluate the extent of organ involvement. A consultation with a medical geneticist or a specialist in metabolic disorders is recommended for accurate diagnosis and management of MPS Type VI. |